Association between visceral fat area and metabolic syndrome in individuals with normal body weight: insights from a Chinese health screening dataset

Background Metabolic syndrome (MetS) is increasingly diagnosed in individuals with normal body weight, and visceral fat emerges as a significant risk factor. However, the relationship between visceral fat area (VFA) and MetS within this population remains inadequately explored, and the diagnostic th...

Full description

Saved in:
Bibliographic Details
Published inLipids in health and disease Vol. 24; no. 1; pp. 57 - 13
Main Authors Sun, Yongbing, Lin, Xinbei, Zou, Zhi, Zhou, Yang, Liu, Ao, Li, Xin, Du, Yawei, Ji, Xiaoqi, Li, Zhonglin, Wu, Xiaoling, Wang, Yong, Lv, Xue, Li, Tao, Zhang, Jiancheng, Guo, Zhiping, Li, Hao, Li, Yongli
Format Journal Article
LanguageEnglish
Published London BioMed Central 18.02.2025
BioMed Central Ltd
BMC
Subjects
Online AccessGet full text
ISSN1476-511X
1476-511X
DOI10.1186/s12944-025-02482-0

Cover

Abstract Background Metabolic syndrome (MetS) is increasingly diagnosed in individuals with normal body weight, and visceral fat emerges as a significant risk factor. However, the relationship between visceral fat area (VFA) and MetS within this population remains inadequately explored, and the diagnostic threshold for MetS in normal-weight individuals is yet to be established. Methods This study used a cross-sectional design combined with longitudinal cohort analysis. Data were collected from 5,944 normal-weight participants who underwent health screenings at Henan Provincial People’s Hospital of China between October 2018 and October 2024. VFA was measured via multislice computed tomography scanning, and VFA-based tertile categorization was applied among the participants. The relationship between VFA and MetS was examined using univariate and multivariate logistic regression analyses. Nonlinear relationship was investigated by restricted cubic spline (RCS) modeling, and diagnostic accuracy was determined by receiver operating characteristic (ROC) curve analysis. Furthermore, data from individuals who completed three or more screenings were used to construct Kaplan–Meier survival curves for MetS events, with significance tested using the log-rank method. Results Among the individuals with a normal BMI, elevated VFA was associated with a high incidence of MetS. After the adjustment for confounders, VFA was significantly associated with MetS risk [odds ratio (OR) = 1.13, 95% confidence interval (CI): 1.12–1.25]. The subjects in the highest VFA tertile showed significantly elevated MetS risk (OR = 30.33; 95% CI: 19.00–48.43, P  < 0.001) versus those in the lowest tertile. The RCS model demonstrated a nonlinear, positive association between VFA and MetS risk ( P for nonlinearity < 0.001), with risk escalation slowing down when the VFA exceeded 100 cm². ROC analysis showed that VFA had the highest diagnostic accuracy for MetS compared with other abdominal fat measures (AUC = 0.844, sensitivity = 0.839, specificity = 0.793, and accuracy = 0.785). In a longitudinal subset of 398 normal-weight participants followed for 6 years, 106 MetS cases occurred, with cumulative incidence rising as VFA increased (log-rank test, P  < 0.001). Conclusion VFA shows an independent, nonlinear, positive association with MetS risk among normal-weight individuals, with a threshold effect at 100 cm². VFA = 162.85 cm² may serve as an accurate and effective predictor for MetS in this population.
AbstractList Background Metabolic syndrome (MetS) is increasingly diagnosed in individuals with normal body weight, and visceral fat emerges as a significant risk factor. However, the relationship between visceral fat area (VFA) and MetS within this population remains inadequately explored, and the diagnostic threshold for MetS in normal-weight individuals is yet to be established. Methods This study used a cross-sectional design combined with longitudinal cohort analysis. Data were collected from 5,944 normal-weight participants who underwent health screenings at Henan Provincial People's Hospital of China between October 2018 and October 2024. VFA was measured via multislice computed tomography scanning, and VFA-based tertile categorization was applied among the participants. The relationship between VFA and MetS was examined using univariate and multivariate logistic regression analyses. Nonlinear relationship was investigated by restricted cubic spline (RCS) modeling, and diagnostic accuracy was determined by receiver operating characteristic (ROC) curve analysis. Furthermore, data from individuals who completed three or more screenings were used to construct Kaplan-Meier survival curves for MetS events, with significance tested using the log-rank method. Results Among the individuals with a normal BMI, elevated VFA was associated with a high incidence of MetS. After the adjustment for confounders, VFA was significantly associated with MetS risk [odds ratio (OR) = 1.13, 95% confidence interval (CI): 1.12-1.25]. The subjects in the highest VFA tertile showed significantly elevated MetS risk (OR = 30.33; 95% CI: 19.00-48.43, P < 0.001) versus those in the lowest tertile. The RCS model demonstrated a nonlinear, positive association between VFA and MetS risk (P for nonlinearity < 0.001), with risk escalation slowing down when the VFA exceeded 100 cm². ROC analysis showed that VFA had the highest diagnostic accuracy for MetS compared with other abdominal fat measures (AUC = 0.844, sensitivity = 0.839, specificity = 0.793, and accuracy = 0.785). In a longitudinal subset of 398 normal-weight participants followed for 6 years, 106 MetS cases occurred, with cumulative incidence rising as VFA increased (log-rank test, P < 0.001). Conclusion VFA shows an independent, nonlinear, positive association with MetS risk among normal-weight individuals, with a threshold effect at 100 cm². VFA = 162.85 cm² may serve as an accurate and effective predictor for MetS in this population. Keywords: Intra-abdominal fat, Metabolic syndrome, Body mass index, Asian continental ancestry group
Metabolic syndrome (MetS) is increasingly diagnosed in individuals with normal body weight, and visceral fat emerges as a significant risk factor. However, the relationship between visceral fat area (VFA) and MetS within this population remains inadequately explored, and the diagnostic threshold for MetS in normal-weight individuals is yet to be established.BACKGROUNDMetabolic syndrome (MetS) is increasingly diagnosed in individuals with normal body weight, and visceral fat emerges as a significant risk factor. However, the relationship between visceral fat area (VFA) and MetS within this population remains inadequately explored, and the diagnostic threshold for MetS in normal-weight individuals is yet to be established.This study used a cross-sectional design combined with longitudinal cohort analysis. Data were collected from 5,944 normal-weight participants who underwent health screenings at Henan Provincial People's Hospital of China between October 2018 and October 2024. VFA was measured via multislice computed tomography scanning, and VFA-based tertile categorization was applied among the participants. The relationship between VFA and MetS was examined using univariate and multivariate logistic regression analyses. Nonlinear relationship was investigated by restricted cubic spline (RCS) modeling, and diagnostic accuracy was determined by receiver operating characteristic (ROC) curve analysis. Furthermore, data from individuals who completed three or more screenings were used to construct Kaplan-Meier survival curves for MetS events, with significance tested using the log-rank method.METHODSThis study used a cross-sectional design combined with longitudinal cohort analysis. Data were collected from 5,944 normal-weight participants who underwent health screenings at Henan Provincial People's Hospital of China between October 2018 and October 2024. VFA was measured via multislice computed tomography scanning, and VFA-based tertile categorization was applied among the participants. The relationship between VFA and MetS was examined using univariate and multivariate logistic regression analyses. Nonlinear relationship was investigated by restricted cubic spline (RCS) modeling, and diagnostic accuracy was determined by receiver operating characteristic (ROC) curve analysis. Furthermore, data from individuals who completed three or more screenings were used to construct Kaplan-Meier survival curves for MetS events, with significance tested using the log-rank method.Among the individuals with a normal BMI, elevated VFA was associated with a high incidence of MetS. After the adjustment for confounders, VFA was significantly associated with MetS risk [odds ratio (OR) = 1.13, 95% confidence interval (CI): 1.12-1.25]. The subjects in the highest VFA tertile showed significantly elevated MetS risk (OR = 30.33; 95% CI: 19.00-48.43, P < 0.001) versus those in the lowest tertile. The RCS model demonstrated a nonlinear, positive association between VFA and MetS risk (P for nonlinearity < 0.001), with risk escalation slowing down when the VFA exceeded 100 cm². ROC analysis showed that VFA had the highest diagnostic accuracy for MetS compared with other abdominal fat measures (AUC = 0.844, sensitivity = 0.839, specificity = 0.793, and accuracy = 0.785). In a longitudinal subset of 398 normal-weight participants followed for 6 years, 106 MetS cases occurred, with cumulative incidence rising as VFA increased (log-rank test, P < 0.001).RESULTSAmong the individuals with a normal BMI, elevated VFA was associated with a high incidence of MetS. After the adjustment for confounders, VFA was significantly associated with MetS risk [odds ratio (OR) = 1.13, 95% confidence interval (CI): 1.12-1.25]. The subjects in the highest VFA tertile showed significantly elevated MetS risk (OR = 30.33; 95% CI: 19.00-48.43, P < 0.001) versus those in the lowest tertile. The RCS model demonstrated a nonlinear, positive association between VFA and MetS risk (P for nonlinearity < 0.001), with risk escalation slowing down when the VFA exceeded 100 cm². ROC analysis showed that VFA had the highest diagnostic accuracy for MetS compared with other abdominal fat measures (AUC = 0.844, sensitivity = 0.839, specificity = 0.793, and accuracy = 0.785). In a longitudinal subset of 398 normal-weight participants followed for 6 years, 106 MetS cases occurred, with cumulative incidence rising as VFA increased (log-rank test, P < 0.001).VFA shows an independent, nonlinear, positive association with MetS risk among normal-weight individuals, with a threshold effect at 100 cm². VFA = 162.85 cm² may serve as an accurate and effective predictor for MetS in this population.CONCLUSIONVFA shows an independent, nonlinear, positive association with MetS risk among normal-weight individuals, with a threshold effect at 100 cm². VFA = 162.85 cm² may serve as an accurate and effective predictor for MetS in this population.
Metabolic syndrome (MetS) is increasingly diagnosed in individuals with normal body weight, and visceral fat emerges as a significant risk factor. However, the relationship between visceral fat area (VFA) and MetS within this population remains inadequately explored, and the diagnostic threshold for MetS in normal-weight individuals is yet to be established. This study used a cross-sectional design combined with longitudinal cohort analysis. Data were collected from 5,944 normal-weight participants who underwent health screenings at Henan Provincial People's Hospital of China between October 2018 and October 2024. VFA was measured via multislice computed tomography scanning, and VFA-based tertile categorization was applied among the participants. The relationship between VFA and MetS was examined using univariate and multivariate logistic regression analyses. Nonlinear relationship was investigated by restricted cubic spline (RCS) modeling, and diagnostic accuracy was determined by receiver operating characteristic (ROC) curve analysis. Furthermore, data from individuals who completed three or more screenings were used to construct Kaplan-Meier survival curves for MetS events, with significance tested using the log-rank method. Among the individuals with a normal BMI, elevated VFA was associated with a high incidence of MetS. After the adjustment for confounders, VFA was significantly associated with MetS risk [odds ratio (OR) = 1.13, 95% confidence interval (CI): 1.12-1.25]. The subjects in the highest VFA tertile showed significantly elevated MetS risk (OR = 30.33; 95% CI: 19.00-48.43, P < 0.001) versus those in the lowest tertile. The RCS model demonstrated a nonlinear, positive association between VFA and MetS risk (P for nonlinearity < 0.001), with risk escalation slowing down when the VFA exceeded 100 cm². ROC analysis showed that VFA had the highest diagnostic accuracy for MetS compared with other abdominal fat measures (AUC = 0.844, sensitivity = 0.839, specificity = 0.793, and accuracy = 0.785). In a longitudinal subset of 398 normal-weight participants followed for 6 years, 106 MetS cases occurred, with cumulative incidence rising as VFA increased (log-rank test, P < 0.001). VFA shows an independent, nonlinear, positive association with MetS risk among normal-weight individuals, with a threshold effect at 100 cm². VFA = 162.85 cm² may serve as an accurate and effective predictor for MetS in this population.
Abstract Background Metabolic syndrome (MetS) is increasingly diagnosed in individuals with normal body weight, and visceral fat emerges as a significant risk factor. However, the relationship between visceral fat area (VFA) and MetS within this population remains inadequately explored, and the diagnostic threshold for MetS in normal-weight individuals is yet to be established. Methods This study used a cross-sectional design combined with longitudinal cohort analysis. Data were collected from 5,944 normal-weight participants who underwent health screenings at Henan Provincial People’s Hospital of China between October 2018 and October 2024. VFA was measured via multislice computed tomography scanning, and VFA-based tertile categorization was applied among the participants. The relationship between VFA and MetS was examined using univariate and multivariate logistic regression analyses. Nonlinear relationship was investigated by restricted cubic spline (RCS) modeling, and diagnostic accuracy was determined by receiver operating characteristic (ROC) curve analysis. Furthermore, data from individuals who completed three or more screenings were used to construct Kaplan–Meier survival curves for MetS events, with significance tested using the log-rank method. Results Among the individuals with a normal BMI, elevated VFA was associated with a high incidence of MetS. After the adjustment for confounders, VFA was significantly associated with MetS risk [odds ratio (OR) = 1.13, 95% confidence interval (CI): 1.12–1.25]. The subjects in the highest VFA tertile showed significantly elevated MetS risk (OR = 30.33; 95% CI: 19.00–48.43, P < 0.001) versus those in the lowest tertile. The RCS model demonstrated a nonlinear, positive association between VFA and MetS risk (P for nonlinearity < 0.001), with risk escalation slowing down when the VFA exceeded 100 cm². ROC analysis showed that VFA had the highest diagnostic accuracy for MetS compared with other abdominal fat measures (AUC = 0.844, sensitivity = 0.839, specificity = 0.793, and accuracy = 0.785). In a longitudinal subset of 398 normal-weight participants followed for 6 years, 106 MetS cases occurred, with cumulative incidence rising as VFA increased (log-rank test, P < 0.001). Conclusion VFA shows an independent, nonlinear, positive association with MetS risk among normal-weight individuals, with a threshold effect at 100 cm². VFA = 162.85 cm² may serve as an accurate and effective predictor for MetS in this population.
Metabolic syndrome (MetS) is increasingly diagnosed in individuals with normal body weight, and visceral fat emerges as a significant risk factor. However, the relationship between visceral fat area (VFA) and MetS within this population remains inadequately explored, and the diagnostic threshold for MetS in normal-weight individuals is yet to be established. This study used a cross-sectional design combined with longitudinal cohort analysis. Data were collected from 5,944 normal-weight participants who underwent health screenings at Henan Provincial People's Hospital of China between October 2018 and October 2024. VFA was measured via multislice computed tomography scanning, and VFA-based tertile categorization was applied among the participants. The relationship between VFA and MetS was examined using univariate and multivariate logistic regression analyses. Nonlinear relationship was investigated by restricted cubic spline (RCS) modeling, and diagnostic accuracy was determined by receiver operating characteristic (ROC) curve analysis. Furthermore, data from individuals who completed three or more screenings were used to construct Kaplan-Meier survival curves for MetS events, with significance tested using the log-rank method. Among the individuals with a normal BMI, elevated VFA was associated with a high incidence of MetS. After the adjustment for confounders, VFA was significantly associated with MetS risk [odds ratio (OR) = 1.13, 95% confidence interval (CI): 1.12-1.25]. The subjects in the highest VFA tertile showed significantly elevated MetS risk (OR = 30.33; 95% CI: 19.00-48.43, P < 0.001) versus those in the lowest tertile. The RCS model demonstrated a nonlinear, positive association between VFA and MetS risk (P for nonlinearity < 0.001), with risk escalation slowing down when the VFA exceeded 100 cm². ROC analysis showed that VFA had the highest diagnostic accuracy for MetS compared with other abdominal fat measures (AUC = 0.844, sensitivity = 0.839, specificity = 0.793, and accuracy = 0.785). In a longitudinal subset of 398 normal-weight participants followed for 6 years, 106 MetS cases occurred, with cumulative incidence rising as VFA increased (log-rank test, P < 0.001). VFA shows an independent, nonlinear, positive association with MetS risk among normal-weight individuals, with a threshold effect at 100 cm². VFA = 162.85 cm² may serve as an accurate and effective predictor for MetS in this population.
Background Metabolic syndrome (MetS) is increasingly diagnosed in individuals with normal body weight, and visceral fat emerges as a significant risk factor. However, the relationship between visceral fat area (VFA) and MetS within this population remains inadequately explored, and the diagnostic threshold for MetS in normal-weight individuals is yet to be established. Methods This study used a cross-sectional design combined with longitudinal cohort analysis. Data were collected from 5,944 normal-weight participants who underwent health screenings at Henan Provincial People’s Hospital of China between October 2018 and October 2024. VFA was measured via multislice computed tomography scanning, and VFA-based tertile categorization was applied among the participants. The relationship between VFA and MetS was examined using univariate and multivariate logistic regression analyses. Nonlinear relationship was investigated by restricted cubic spline (RCS) modeling, and diagnostic accuracy was determined by receiver operating characteristic (ROC) curve analysis. Furthermore, data from individuals who completed three or more screenings were used to construct Kaplan–Meier survival curves for MetS events, with significance tested using the log-rank method. Results Among the individuals with a normal BMI, elevated VFA was associated with a high incidence of MetS. After the adjustment for confounders, VFA was significantly associated with MetS risk [odds ratio (OR) = 1.13, 95% confidence interval (CI): 1.12–1.25]. The subjects in the highest VFA tertile showed significantly elevated MetS risk (OR = 30.33; 95% CI: 19.00–48.43, P  < 0.001) versus those in the lowest tertile. The RCS model demonstrated a nonlinear, positive association between VFA and MetS risk ( P for nonlinearity < 0.001), with risk escalation slowing down when the VFA exceeded 100 cm². ROC analysis showed that VFA had the highest diagnostic accuracy for MetS compared with other abdominal fat measures (AUC = 0.844, sensitivity = 0.839, specificity = 0.793, and accuracy = 0.785). In a longitudinal subset of 398 normal-weight participants followed for 6 years, 106 MetS cases occurred, with cumulative incidence rising as VFA increased (log-rank test, P  < 0.001). Conclusion VFA shows an independent, nonlinear, positive association with MetS risk among normal-weight individuals, with a threshold effect at 100 cm². VFA = 162.85 cm² may serve as an accurate and effective predictor for MetS in this population.
ArticleNumber 57
Audience Academic
Author Lin, Xinbei
Sun, Yongbing
Zou, Zhi
Li, Hao
Guo, Zhiping
Ji, Xiaoqi
Li, Xin
Wang, Yong
Liu, Ao
Li, Tao
Li, Yongli
Zhou, Yang
Du, Yawei
Li, Zhonglin
Wu, Xiaoling
Lv, Xue
Zhang, Jiancheng
Author_xml – sequence: 1
  givenname: Yongbing
  surname: Sun
  fullname: Sun, Yongbing
  organization: Department of Medical Imaging, Zhengzhou University People’s Hospital, Henan Provincial People’s Hospital
– sequence: 2
  givenname: Xinbei
  surname: Lin
  fullname: Lin, Xinbei
  organization: Department of Medical Imaging, Zhengzhou University People’s Hospital, Henan Provincial People’s Hospital
– sequence: 3
  givenname: Zhi
  surname: Zou
  fullname: Zou, Zhi
  organization: Department of Medical Imaging, Zhengzhou University People’s Hospital, Henan Provincial People’s Hospital
– sequence: 4
  givenname: Yang
  surname: Zhou
  fullname: Zhou, Yang
  organization: Department of Medical Imaging, Zhengzhou University People’s Hospital, Henan Provincial People’s Hospital
– sequence: 5
  givenname: Ao
  surname: Liu
  fullname: Liu, Ao
  organization: Department of Medical Imaging, Zhengzhou University People’s Hospital, Henan Provincial People’s Hospital
– sequence: 6
  givenname: Xin
  surname: Li
  fullname: Li, Xin
  organization: Department of Medical Imaging, Henan University People’s Hospital, Henan Provincial People’s Hospital
– sequence: 7
  givenname: Yawei
  surname: Du
  fullname: Du, Yawei
  organization: Department of Medical Imaging, Henan University People’s Hospital, Henan Provincial People’s Hospital
– sequence: 8
  givenname: Xiaoqi
  surname: Ji
  fullname: Ji, Xiaoqi
  organization: Department of Medical Imaging, Zhengzhou University People’s Hospital, Henan Provincial People’s Hospital
– sequence: 9
  givenname: Zhonglin
  surname: Li
  fullname: Li, Zhonglin
  organization: Department of Medical Imaging, Zhengzhou University People’s Hospital, Henan Provincial People’s Hospital
– sequence: 10
  givenname: Xiaoling
  surname: Wu
  fullname: Wu, Xiaoling
  organization: Department of Nuclear Medicine, Henan Provincial People’s Hospital
– sequence: 11
  givenname: Yong
  surname: Wang
  fullname: Wang, Yong
  organization: Henan Provincial People’s Hospital
– sequence: 12
  givenname: Xue
  surname: Lv
  fullname: Lv, Xue
  organization: Henan Provincial People’s Hospital
– sequence: 13
  givenname: Tao
  surname: Li
  fullname: Li, Tao
  organization: Chronic Health Management Laboratory, Fuwai Central China Cardiovascular Hospital
– sequence: 14
  givenname: Jiancheng
  surname: Zhang
  fullname: Zhang, Jiancheng
  organization: Department of Gastrointestinal Surgery, Henan Provincial People’s Hospital
– sequence: 15
  givenname: Zhiping
  surname: Guo
  fullname: Guo, Zhiping
  organization: Chronic Health Management Laboratory, Fuwai Central China Cardiovascular Hospital
– sequence: 16
  givenname: Hao
  surname: Li
  fullname: Li, Hao
  email: leehao2004@163.com
  organization: Chronic Health Management Laboratory, Fuwai Central China Cardiovascular Hospital
– sequence: 17
  givenname: Yongli
  surname: Li
  fullname: Li, Yongli
  email: shyliyongli@126.com
  organization: Department of Health Management, Henan Provincial People’s Hospital, Chronic Health Management Laboratory, Zhengzhou University People’s Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39966964$$D View this record in MEDLINE/PubMed
BookMark eNp9ksuK2zAUhk2Z0rm0L9BFEXTTjaeSrch2NyWEXgYGummhO3EsHTsKtjSVnIQ8SN-3J-PpMIFSLCMhff-vy_kvszMfPGbZa8GvhajV-ySKRsqcFwv6ZV3k_Fl2IWSl8oUQP8-ejM-zy5Q2nBe8UupFdl42jVKNkhfZ72VKwTiYXPCsxWmP6NnOJYMRBtbBxCAiMPCWjThBGwZnWDp4G8OIzHlq1u2c3cKQ2N5Na-ZDHEnaBntge3T9evpAUDoOEutIxoCt1s5jQrZGGEiSTKRtne-ZhQkSTi-z5x0Z4quH_ir78fnT99XX_Pbbl5vV8jY3i1JMuSjLtqk4B2lMqQpuVSdQCNtURjTcWivqWhblomsbKEqUsiqsbUABKiNN3ZVX2c3sawNs9F10I8SDDuD0_USIvYY4OTOgppfDYiFqW9lKtp1orVJtBy3WdQ2KA3l9nL3utu2I1qCf6AlPTE9XvFvrPuw01bKslFyQw7sHhxh-bTFNejwWYhjAY9gmXQpVl42oZEPo2xntgc7mfBfI0hxxvayLmiotuSLq-h8UfRZHZyhMnaP5E8Gbp3d4PPzfvBBQzICJIaWI3SMi-PEiSs-h1BRKfR9KzUlUzqJEsO8x6k3YRk-F_Z_qD2pv5rE
Cites_doi 10.2337/diacare.26.3.650
10.3904/kjim.2018.427
10.1210/clinem/dgad152
10.1155/2013/378632
10.1016/j.tem.2008.10.006
10.1155/2013/393192
10.1038/nrdp.2017.34
10.1136/bmjopen-2016-013831
10.3390/nu5041218
10.1016/j.metabol.2020.154456
10.1161/CIRCULATIONAHA.106.675355
10.1291/hypres.31.1283
10.1111/cpf.12700
10.1152/ajpregu.00653.2001
10.1111/jdi.13306
10.1074/jbc.M300423200
10.1007/s11154-013-9252-x
10.1016/j.ebiom.2018.10.025
10.1074/jbc.M210689200
10.1093/ajcn/79.3.379
10.3390/nu11061430
10.1136/bmjopen-2020-048221
10.1016/j.pcad.2018.07.003
10.1155/2012/584541
10.7326/0003-4819-145-4-200608150-00004
10.1016/j.clnu.2019.07.012
10.1186/s12933-023-01765-z
10.1038/s41572-024-00563-5
10.3389/fpubh.2023.1073824
10.3390/nu5030928
10.1002/advs.202103719
10.1016/j.dsx.2017.03.006
10.1111/joim.13355
10.1002/cac2.12393
10.3389/fendo.2024.1411678
10.1016/j.cmet.2023.01.006
10.1038/s41591-024-03095-3
10.4082/kjfm.17.0099
10.1016/j.dsx.2022.102584
10.1159/000520418
10.3390/ijerph16214152
10.4082/kjfm.18.0122
10.1016/j.jcmg.2014.07.017
10.1111/dme.14060
10.18544/PEDM-23.02.0079
10.3346/jkms.2011.26.7.906
10.1007/s11906-018-0812-z
10.2147/DMSO.S483497
10.1111/obr.13767
10.3109/07853890.2010.526138
10.1016/j.orcp.2017.10.005
10.1016/S2213-8587(23)00086-4
10.1259/bjr/38447238
ContentType Journal Article
Copyright The Author(s) 2025
2025. The Author(s).
COPYRIGHT 2025 BioMed Central Ltd.
The Author(s) 2025 2025
Copyright_xml – notice: The Author(s) 2025
– notice: 2025. The Author(s).
– notice: COPYRIGHT 2025 BioMed Central Ltd.
– notice: The Author(s) 2025 2025
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1186/s12944-025-02482-0
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Open Access Full Text
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic


MEDLINE

Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1476-511X
EndPage 13
ExternalDocumentID oai_doaj_org_article_076e2518d7d74bf1bd66bfabe888a60a
PMC11837645
A828002406
39966964
10_1186_s12944_025_02482_0
Genre Journal Article
GeographicLocations China
Japan
GeographicLocations_xml – name: China
– name: Japan
GrantInformation_xml – fundername: Medical Science and Technology Research Project of Henan Province
  grantid: SBGJ202402100; LHGJ20230074
– fundername: Central Plains Science and Technology Innovation leading talent Program
  grantid: 244200510016
– fundername: Key scientific research project of Henan University
  grantid: 25A310026
– fundername: Henan Provincial Science and Technology Tackling Program Project Funding
  grantid: 242102311121; 222102310283
– fundername: National Key Research and Development Program of China
  grantid: 2022YFC2010001
  funderid: http://dx.doi.org/10.13039/501100012166
– fundername: Independent Innovation Project of Zhengzhou University
  grantid: ZC20240105
– fundername: Key Science and Technology Projects of Henan Province
  grantid: 241100310300
– fundername: National Key Research and Development Program of China
  grantid: 2022YFC2010001
GroupedDBID ---
0R~
29L
2WC
53G
5GY
5VS
7X7
88E
8FE
8FH
8FI
8FJ
A8Z
AAFWJ
AAHBH
AAJSJ
AASML
ABDBF
ABUWG
ACGFO
ACGFS
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BBNVY
BCNDV
BENPR
BFQNJ
BHPHI
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESTFP
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IGS
IHR
INH
INR
ITC
KQ8
LK8
M1P
M7P
M~E
O5R
O5S
OK1
OVT
P2P
P6G
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
U2A
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
ALIPV
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7X8
5PM
ID FETCH-LOGICAL-c531t-133b9700a4cc3620d6f1e11d97c190ddd1884235fb9a23e4472dd9a6ae6c4c8f3
IEDL.DBID DOA
ISSN 1476-511X
IngestDate Wed Aug 27 01:30:18 EDT 2025
Thu Aug 21 18:28:39 EDT 2025
Mon Sep 08 14:52:28 EDT 2025
Tue Jun 17 21:59:24 EDT 2025
Tue Jun 10 20:57:50 EDT 2025
Sat May 10 01:40:59 EDT 2025
Tue Jul 01 05:42:15 EDT 2025
Sat Sep 06 07:34:19 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Intra-abdominal fat
Body mass index
Asian continental ancestry group
Metabolic syndrome
Language English
License 2025. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c531t-133b9700a4cc3620d6f1e11d97c190ddd1884235fb9a23e4472dd9a6ae6c4c8f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doaj.org/article/076e2518d7d74bf1bd66bfabe888a60a
PMID 39966964
PQID 3168391749
PQPubID 23479
PageCount 13
ParticipantIDs doaj_primary_oai_doaj_org_article_076e2518d7d74bf1bd66bfabe888a60a
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11837645
proquest_miscellaneous_3168391749
gale_infotracmisc_A828002406
gale_infotracacademiconefile_A828002406
pubmed_primary_39966964
crossref_primary_10_1186_s12944_025_02482_0
springer_journals_10_1186_s12944_025_02482_0
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-02-18
PublicationDateYYYYMMDD 2025-02-18
PublicationDate_xml – month: 02
  year: 2025
  text: 2025-02-18
  day: 18
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Lipids in health and disease
PublicationTitleAbbrev Lipids Health Dis
PublicationTitleAlternate Lipids Health Dis
PublicationYear 2025
Publisher BioMed Central
BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: BMC
References RN Bergman (2482_CR39) 2006; 14
J Ye (2482_CR7) 2023; 108
B Klop (2482_CR40) 2013; 5
J Gui (2482_CR5) 2023; 11
Q Zeng (2482_CR23) 2021; 115
N Stefan (2482_CR3) 2023; 11
I Dichi (2482_CR30) 2012; 2012
B Muhlhausler (2482_CR35) 2009; 20
M Katahira (2482_CR53) 2022; 16
2482_CR38
CM Phillips (2482_CR12) 2013; 14
RM Sandsdal (2482_CR6) 2023; 22
HH Jeon (2482_CR19) 2021; 36
L Huo (2482_CR24) 2019; 36
Y Tatsumi (2482_CR18) 2017; 7
BF Zhou (2482_CR21) 2002; 15
D Nikolic (2482_CR43) 2013; 5
JP Bennett (2482_CR47) 2024; 25
A Hiuge-Shimizu (2482_CR48) 2012; 44
R Feng (2482_CR17) 2023; 43
MG Saklayen (2482_CR4) 2018; 20
P González-Muniesa (2482_CR11) 2017; 3
C Torun (2482_CR51) 2024; 15
GJ Brewer (2482_CR14) 2021; 41
N Stefan (2482_CR42) 2023; 7
2482_CR28
IJ Neeland (2482_CR1) 2024; 10
LM Pammer (2482_CR2) 2021; 290
T Tchkonia (2482_CR34) 2002; 282
D Nagayama (2482_CR16) 2022; 15
RV Shah (2482_CR52) 2014; 7
A Lee (2482_CR54) 2018; 39
Z Xu (2482_CR15) 2021; 11
H Zand (2482_CR36) 2017; 11
H Nishizawa (2482_CR10) 2019; 11
CS Fox (2482_CR29) 2007; 116
L Busetto (2482_CR9) 2024; 30
H Duan (2482_CR45) 2022; 9
OY Bello-Chavolla (2482_CR50) 2020; 39
T Hayashi (2482_CR56) 2003; 26
HI Kim (2482_CR46) 2011; 26
I Janssen (2482_CR13) 2004; 79
AS Levey (2482_CR22) 2006; 145
B Wang (2482_CR8) 2018; 12
Z Gao (2482_CR32) 2003; 278
N Stefan (2482_CR41) 2024; 13
A Shuster (2482_CR55) 2012; 85
J Wu (2482_CR20) 2024; 17
V Rakotoarivelo (2482_CR31) 2018; 37
JJ Senn (2482_CR33) 2003; 278
E Araki (2482_CR49) 2020; 11
L Wang (2482_CR25) 2013; 2013
YH Lee (2482_CR44) 2020; 41
A Elagizi (2482_CR26) 2018; 61
E Oda (2482_CR37) 2008; 31
Z Zdrojewicz (2482_CR27) 2017; 23
References_xml – volume: 26
  start-page: 650
  year: 2003
  ident: 2482_CR56
  publication-title: Diabetes Care
  doi: 10.2337/diacare.26.3.650
– volume: 36
  start-page: 97
  year: 2021
  ident: 2482_CR19
  publication-title: Korean J Intern Med
  doi: 10.3904/kjim.2018.427
– volume: 108
  start-page: 2240
  year: 2023
  ident: 2482_CR7
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/clinem/dgad152
– volume: 2013
  start-page: 378632
  year: 2013
  ident: 2482_CR25
  publication-title: Int J Endocrinol
  doi: 10.1155/2013/378632
– volume: 20
  start-page: 51
  year: 2009
  ident: 2482_CR35
  publication-title: Trends Endocrinol Metab
  doi: 10.1016/j.tem.2008.10.006
– ident: 2482_CR38
  doi: 10.1155/2013/393192
– volume: 3
  start-page: 17034
  year: 2017
  ident: 2482_CR11
  publication-title: Nat Rev Dis Primers
  doi: 10.1038/nrdp.2017.34
– volume: 7
  start-page: e013831
  year: 2017
  ident: 2482_CR18
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2016-013831
– volume: 15
  start-page: 83
  year: 2002
  ident: 2482_CR21
  publication-title: Biomed Environ Sci
– volume: 5
  start-page: 1218
  year: 2013
  ident: 2482_CR40
  publication-title: Nutrients
  doi: 10.3390/nu5041218
– volume: 115
  start-page: 154456
  year: 2021
  ident: 2482_CR23
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2020.154456
– volume: 116
  start-page: 39
  year: 2007
  ident: 2482_CR29
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.106.675355
– volume: 31
  start-page: 1283
  year: 2008
  ident: 2482_CR37
  publication-title: Hypertens Res
  doi: 10.1291/hypres.31.1283
– volume: 41
  start-page: 317
  year: 2021
  ident: 2482_CR14
  publication-title: Clin Physiol Funct Imaging
  doi: 10.1111/cpf.12700
– volume: 282
  start-page: R1286
  year: 2002
  ident: 2482_CR34
  publication-title: Am J Physiol Regul Integr Comp Physiol
  doi: 10.1152/ajpregu.00653.2001
– volume: 11
  start-page: 1020
  year: 2020
  ident: 2482_CR49
  publication-title: J Diabetes Investig
  doi: 10.1111/jdi.13306
– volume: 278
  start-page: 24944
  issue: 27
  year: 2003
  ident: 2482_CR32
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M300423200
– volume: 14
  start-page: 219
  year: 2013
  ident: 2482_CR12
  publication-title: Rev Endocr Metab Disord
  doi: 10.1007/s11154-013-9252-x
– volume: 37
  start-page: 564
  year: 2018
  ident: 2482_CR31
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2018.10.025
– volume: 278
  start-page: 13740
  issue: 16
  year: 2003
  ident: 2482_CR33
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M210689200
– volume: 79
  start-page: 379
  year: 2004
  ident: 2482_CR13
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/79.3.379
– volume: 11
  start-page: 1430
  year: 2019
  ident: 2482_CR10
  publication-title: Nutrients
  doi: 10.3390/nu11061430
– volume: 11
  start-page: e048221
  year: 2021
  ident: 2482_CR15
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2020-048221
– volume: 61
  start-page: 142
  year: 2018
  ident: 2482_CR26
  publication-title: Prog Cardiovasc Dis
  doi: 10.1016/j.pcad.2018.07.003
– volume: 2012
  start-page: 584541
  year: 2012
  ident: 2482_CR30
  publication-title: J Nutr Metab
  doi: 10.1155/2012/584541
– volume: 145
  start-page: 247
  year: 2006
  ident: 2482_CR22
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-145-4-200608150-00004
– volume: 39
  start-page: 1613
  year: 2020
  ident: 2482_CR50
  publication-title: Clin Nutr
  doi: 10.1016/j.clnu.2019.07.012
– volume: 22
  start-page: 41
  year: 2023
  ident: 2482_CR6
  publication-title: Cardiovasc Diabetol
  doi: 10.1186/s12933-023-01765-z
– volume: 10
  start-page: 77
  year: 2024
  ident: 2482_CR1
  publication-title: Nat Rev Dis Primers
  doi: 10.1038/s41572-024-00563-5
– volume: 11
  start-page: 1073824
  year: 2023
  ident: 2482_CR5
  publication-title: Front Public Health
  doi: 10.3389/fpubh.2023.1073824
– volume: 5
  start-page: 928
  year: 2013
  ident: 2482_CR43
  publication-title: Nutrients
  doi: 10.3390/nu5030928
– volume: 9
  start-page: e2103719
  year: 2022
  ident: 2482_CR45
  publication-title: Adv Sci (Weinh)
  doi: 10.1002/advs.202103719
– volume: 11
  start-page: S307
  issue: Suppl 1
  year: 2017
  ident: 2482_CR36
  publication-title: Diabetes Metab Syndr
  doi: 10.1016/j.dsx.2017.03.006
– volume: 290
  start-page: 1219
  year: 2021
  ident: 2482_CR2
  publication-title: J Intern Med
  doi: 10.1111/joim.13355
– volume: 43
  start-page: 75
  year: 2023
  ident: 2482_CR17
  publication-title: Cancer Commun (Lond)
  doi: 10.1002/cac2.12393
– volume: 15
  start-page: 1411678
  year: 2024
  ident: 2482_CR51
  publication-title: Front Endocrinol (Lausanne)
  doi: 10.3389/fendo.2024.1411678
– volume: 14
  start-page: s16
  issue: Suppl 1
  year: 2006
  ident: 2482_CR39
  publication-title: Obes (Silver Spring)
– volume: 7
  start-page: 236
  issue: 2
  year: 2023
  ident: 2482_CR42
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2023.01.006
– volume: 30
  start-page: 2395
  year: 2024
  ident: 2482_CR9
  publication-title: Nat Med
  doi: 10.1038/s41591-024-03095-3
– volume: 39
  start-page: 239
  year: 2018
  ident: 2482_CR54
  publication-title: Korean J Fam Med
  doi: 10.4082/kjfm.17.0099
– volume: 16
  start-page: 102584
  year: 2022
  ident: 2482_CR53
  publication-title: Diabetes Metab Syndr
  doi: 10.1016/j.dsx.2022.102584
– volume: 15
  start-page: 160
  year: 2022
  ident: 2482_CR16
  publication-title: Obes Facts
  doi: 10.1159/000520418
– ident: 2482_CR28
  doi: 10.3390/ijerph16214152
– volume: 41
  start-page: 229
  year: 2020
  ident: 2482_CR44
  publication-title: Korean J Fam Med
  doi: 10.4082/kjfm.18.0122
– volume: 7
  start-page: 1221
  year: 2014
  ident: 2482_CR52
  publication-title: JACC Cardiovasc Imaging
  doi: 10.1016/j.jcmg.2014.07.017
– volume: 36
  start-page: 1268
  year: 2019
  ident: 2482_CR24
  publication-title: Diabet Med
  doi: 10.1111/dme.14060
– volume: 23
  start-page: 96
  year: 2017
  ident: 2482_CR27
  publication-title: Pediatr Endocrinol Diabetes Metab
  doi: 10.18544/PEDM-23.02.0079
– volume: 26
  start-page: 906
  year: 2011
  ident: 2482_CR46
  publication-title: J Korean Med Sci
  doi: 10.3346/jkms.2011.26.7.906
– volume: 20
  start-page: 12
  year: 2018
  ident: 2482_CR4
  publication-title: Curr Hypertens Rep
  doi: 10.1007/s11906-018-0812-z
– volume: 17
  start-page: 3509
  year: 2024
  ident: 2482_CR20
  publication-title: Diabetes Metab Syndr Obes
  doi: 10.2147/DMSO.S483497
– volume: 13
  start-page: S2213
  year: 2024
  ident: 2482_CR41
  publication-title: Lancet Diabetes Endocrinol
– volume: 25
  start-page: e13767
  year: 2024
  ident: 2482_CR47
  publication-title: Obes Rev
  doi: 10.1111/obr.13767
– volume: 44
  start-page: 82
  year: 2012
  ident: 2482_CR48
  publication-title: Ann Med
  doi: 10.3109/07853890.2010.526138
– volume: 12
  start-page: 61
  year: 2018
  ident: 2482_CR8
  publication-title: Obes Res Clin Pract
  doi: 10.1016/j.orcp.2017.10.005
– volume: 11
  start-page: 426
  year: 2023
  ident: 2482_CR3
  publication-title: Lancet Diabetes Endocrinol
  doi: 10.1016/S2213-8587(23)00086-4
– volume: 85
  start-page: 1
  year: 2012
  ident: 2482_CR55
  publication-title: Br J Radiol
  doi: 10.1259/bjr/38447238
SSID ssj0020766
Score 2.4066148
Snippet Background Metabolic syndrome (MetS) is increasingly diagnosed in individuals with normal body weight, and visceral fat emerges as a significant risk factor....
Metabolic syndrome (MetS) is increasingly diagnosed in individuals with normal body weight, and visceral fat emerges as a significant risk factor. However, the...
Background Metabolic syndrome (MetS) is increasingly diagnosed in individuals with normal body weight, and visceral fat emerges as a significant risk factor....
Abstract Background Metabolic syndrome (MetS) is increasingly diagnosed in individuals with normal body weight, and visceral fat emerges as a significant risk...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 57
SubjectTerms Adipose tissues
Adult
Aged
Analysis
Asian continental ancestry group
Biomedical and Life Sciences
Body Mass Index
Body Weight
Care and treatment
China - epidemiology
Clinical Nutrition
Cross-Sectional Studies
CT imaging
Diagnosis
Female
Health aspects
Humans
Intra-abdominal fat
Intra-Abdominal Fat - diagnostic imaging
Intra-Abdominal Fat - pathology
Life Sciences
Lipidology
Longitudinal Studies
Male
Medical Biochemistry
Medical screening
Metabolic diseases
Metabolic syndrome
Metabolic Syndrome - diagnosis
Metabolic Syndrome - diagnostic imaging
Metabolic Syndrome - epidemiology
Metabolic Syndrome - pathology
Methods
Middle Aged
Risk Factors
ROC Curve
SummonAdditionalLinks – databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ba9VAEF6kgvgi2nqJVhlB9EGD2WSzyfp2PFiKUJ8s9G3ZWzDQ5hSTKv0h_l9nNsnhpIrgW8huSLJz3535hrFXAk2S8UGkzpVFKjzqQYt-f6pU7n1huXARZ_bkizw-FZ_PyrMJJodqYXbP73kt3_doj4RIqekqoW_lKYbnt0tUvJS-t5brbXCF8bici2L--tzC8ER8_j-18I4ZupkieeOcNJqfo_vs3uQ3wmok9AN2K3T77GDVYcx8cQ2vIWZyxi3yfXbnZDowP2C_dpYfppws-NH2jraioDEDGPQawXQeLsKADHHeOphRDKDtoN0WbPVAe7bQkZN7Dnbjr-Fn3Ff9gJN6uuiBilXAADXlDn2AscgSUDPha_G3gPJR-zA8ZKdHn76uj9OpE0OKFOTUr76wqsoyI5xDi5d52fDAuVeVQ4fCe8_rGv2ysrHK5EUQokJKKyNNkE64uikesb1u04UnDFwp8hC4UZmRwjprqdLOECxgI7xQVcLezmTSlyPgho6BSi31SFSNRNWRqDpL2Eei5HYmgWXHG8hDepI9jawR0I2rfeUrYRtuvZS2MTZg9G9kZhL2hvhAk0gjsZ2ZKhPwgwkcS68wKo1YcDJhh4uZKIpuMfxy5iRNQ5S_1oXNVa-pPViBkbFQCXs8ctb2mwsKOZUUCasXPLf4qeVI136LSOC4KmggRJmwdzN76kkH9f9Ytaf_N_0Zu5uPgpTy-pDtDd-vwnN0xQb7Isrgb_0LLbU
  priority: 102
  providerName: Springer Nature
Title Association between visceral fat area and metabolic syndrome in individuals with normal body weight: insights from a Chinese health screening dataset
URI https://link.springer.com/article/10.1186/s12944-025-02482-0
https://www.ncbi.nlm.nih.gov/pubmed/39966964
https://www.proquest.com/docview/3168391749
https://pubmed.ncbi.nlm.nih.gov/PMC11837645
https://doaj.org/article/076e2518d7d74bf1bd66bfabe888a60a
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVFSB
  databaseName: Free Full-Text Journals in Chemistry
  customDbUrl:
  eissn: 1476-511X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0020766
  issn: 1476-511X
  databaseCode: HH5
  dateStart: 20020101
  isFulltext: true
  titleUrlDefault: http://abc-chemistry.org/
  providerName: ABC ChemistRy
– providerCode: PRVADU
  databaseName: BioMed Central_OA刊
  customDbUrl:
  eissn: 1476-511X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0020766
  issn: 1476-511X
  databaseCode: RBZ
  dateStart: 20020101
  isFulltext: true
  titleUrlDefault: https://www.biomedcentral.com/search/
  providerName: BioMedCentral
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1476-511X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0020766
  issn: 1476-511X
  databaseCode: KQ8
  dateStart: 20020101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1476-511X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0020766
  issn: 1476-511X
  databaseCode: KQ8
  dateStart: 20020901
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1476-511X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0020766
  issn: 1476-511X
  databaseCode: DOA
  dateStart: 20020101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 1476-511X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0020766
  issn: 1476-511X
  databaseCode: ABDBF
  dateStart: 20020101
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1476-511X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0020766
  issn: 1476-511X
  databaseCode: DIK
  dateStart: 20020101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1476-511X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0020766
  issn: 1476-511X
  databaseCode: GX1
  dateStart: 20020101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1476-511X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0020766
  issn: 1476-511X
  databaseCode: M~E
  dateStart: 20020101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central (ODIN)
  customDbUrl:
  eissn: 1476-511X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0020766
  issn: 1476-511X
  databaseCode: RPM
  dateStart: 20020101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1476-511X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0020766
  issn: 1476-511X
  databaseCode: 7X7
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1476-511X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0020766
  issn: 1476-511X
  databaseCode: BENPR
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: Springer Nature HAS Fully OA
  customDbUrl:
  eissn: 1476-511X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0020766
  issn: 1476-511X
  databaseCode: AAJSJ
  dateStart: 20021201
  isFulltext: true
  titleUrlDefault: https://www.springernature.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: Springer Nature OA Free Journals
  customDbUrl:
  eissn: 1476-511X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0020766
  issn: 1476-511X
  databaseCode: C6C
  dateStart: 20021201
  isFulltext: true
  titleUrlDefault: http://www.springeropen.com/
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: SpringerLink Journals (ICM)
  customDbUrl:
  eissn: 1476-511X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0020766
  issn: 1476-511X
  databaseCode: U2A
  dateStart: 20021201
  isFulltext: true
  titleUrlDefault: http://www.springerlink.com/journals/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9RAEB-0gvgi2voRrccIog8amo-9TeLb9WgpQouIB_e27FfoQZsTc1X6h_j_OrNJyqWCvvhy5G433GZ_szszm5nfALwRpJK08yK2dprHwtE-aMjuj6sqcy43qbCBZ_b0TJ4sxKfldLlV6otjwjp64G7iDsjP9qSDS1e4Qpg6NU5KU2vjyXXTMgmmEamxwZnqXS26Sw4pMqU8aEmrCRFz6Vbm8MriZKSGAlv_n3vyllK6HTB5661pUEbHj-Bhb0XirBv9Y7jjm13YmzXkQV9e41sMcZ3hwHwX7p_2r8_34NcWGNhHaOGPVWv5YAprvUFNNiTqxuGl35B4XKwsDpwGuGpwdZO-1SKf4GLDJu8FmrW7xp_hlPUjdWr5okVOXUGNXKLbtx67lEukfYr-lh4LOTq19ZsnsDg--jo_ifu6DDHhmXL1-txURZJoYS3pv8TJOvVp6qrCknnhnEvLkqy0aW0qneVeiIJwr7TUXlphyzp_CjvNuvHPAe1UZN6nukq0FMYaw3l3mkkCa-FEVUTwfoBJfevoN1RwW0qpOlAVgaoCqCqJ4JCRvOnJ1NnhBxIo1QuU-pdARfCO5UDxAiewre7zFGjATJWlZuSjBmY4GcH-qCctTDtqfj1IkuImjmZr_PqqVVwsLCc_WVQRPOsk62bMOTuglRQRlCOZGz3UuKVZnQdecJoVUhdiGsGHQTxVvyO1f5m1F_9j1l7Cg6xbXnFa7sPO5vuVf0Xm2sZM4G6xLCZw7_Do7PMX-jaX80lYrfS5yGa_AfsyQo0
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6hrQRcELQ8AgUGCcEBoiYbx3G4LYhqWbq90Eq9WX4FIrVZ1GxB_SH8X8ZOsmoKQuIWrb3K45vxzNgz3wC8ZGSSlHUsNibPYmZpHdTk98dlObU20ykzgWd2ecjnx2xxkp_0RWHtkO0-HEmGlTqoteB7LVkmxmLfftXzcE1jCtS3RJ5zNoGt2WzxZbEJtCg250OBzF__OTJCgav_zxX5ikm6ni557cw0mKL9u3Cn9yFx1oF-D264Zht2Zg3Fz2eX-ApDVmfYLt-Gm8v-8HwHfl2BAvv8LPxRt8ZvS2Gl1qjIg0TVWDxzaxKO09rgwGiAdYP1pnirRb9_i413eE9Rr-wl_gx7rO9oUusvWvSFK6jQN-h2rcOu4BJplaLb0muhz01t3fo-HO9_PPowj_uuDDGhmfre9ZkuiyRRzBiyfonlVerS1JaFIefCWpsKQT5aXulSTTPHWEGol4orxw0zosoewKRZNe4RoMnZ1LlUlYniTButfdWd8hSBFbOsLCJ4M8Akv3fkGzIELYLLDlRJoMoAqkwieO-R3Mz0xNnhh9X5V9nroSTRcOTSCVvYgukq1ZZzXSnthBCKJyqC114OpFdvAtuovkqBHtgTZckZRaiBF45HsDuaSWppRsMvBkmSfsjnsjVuddFK3yosoyiZlRE87CRr88yZDz9LziIQI5kbvdR4pKm_BVZw-ipkLFgewdtBPGW_HrX_-GqP_2_6c7g1P1oeyINPh5-fwO1pp1RxKnZhsj6_cE_JRVvrZ71G_gZmlzYW
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9RAEF-kheKLaOtHtOoIog8amlw2m41v58dRT1sELfRt2a_UgzZXmlTpH-L_68wmOS5VBN_C7R75mN_szOzO_Iax5xxNknaex9bmWcwdroMG_f64LCfOZSblNvDMHhyK_SM-P86P16r4Q7b7cCTZ1TQQS1Pd7p27qlNxKfYatFKcx9SKlTi5JjEG7ZsyLwWGX5vT6fzrfBV0YZwuhmKZv_5zZJACb_-fq_OaebqeOnnt_DSYpdltdqv3J2HaAeAOu-HrbbYzrTGWPruCFxAyPMPW-TbbOugP0nfYrzWxQJ-rBT8WjaUtKqh0Cxq9SdC1gzPfIlBOFxYGdgNY1LBYFXI1QHu5UJPzewpm6a7gZ9hvfYOTGrpogIpYQAM16_aNh674EnDFwtviawHlqTa-vcuOZh--vduP-w4NMUo2pT72mSmLJNHcWrSEiRNV6tPUlYVFR8M5l0qJ_lpemVJPMs95gQgotdBeWG5lld1jG_Wy9g8Y2JxPvE91mWjBjTWGKvA00QVW3PGyiNirQUzqvCPiUCGAkUJ1QlUoVBWEqpKIvSVJrmYSiXb4YXlxonqdVAgNj-6ddIUruKlS44QwlTZeSqlFoiP2knCgSNVR2Fb3FQv4wESapaYYrQaOOBGx3dFMVFE7Gn42IEnREOW11X552ShqG5ZhxMzLiN3vkLV65oxC0VLwiMkR5kYvNR6pF98DQzh-FTQcPI_Y6wGeql-bmn98tYf_N_0p2_ryfqY-fzz89IjdnHQ6Fadyl220F5f-MXprrXnSK-RvrSM6YA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+visceral+fat+area+and+metabolic+syndrome+in+individuals+with+normal+body+weight%3A+insights+from+a+Chinese+health+screening+dataset&rft.jtitle=Lipids+in+health+and+disease&rft.au=Yongbing+Sun&rft.au=Xinbei+Lin&rft.au=Zhi+Zou&rft.au=Yang+Zhou&rft.date=2025-02-18&rft.pub=BMC&rft.eissn=1476-511X&rft.volume=24&rft.issue=1&rft.spage=1&rft.epage=13&rft_id=info:doi/10.1186%2Fs12944-025-02482-0&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_076e2518d7d74bf1bd66bfabe888a60a
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1476-511X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1476-511X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1476-511X&client=summon